Idogen
Idogen: More delays and uncertainty (Redeye)

2019-01-22 14:11
Idogen's pre-clinical program is expanded and extended, meaning clinical studies will be postponed. Further, a new analysis of earlier findings suggest the concept needs more work and changes in the "recipe," creating uncertainty around the path forward.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -